Fig. 7
From: Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases
Fatty liver and hepatic injury evaluation. HFD-fed C57BL/6J mice were treated with various BBR formulations by gavage (n = 10 for each group). Untreated mice fed with HFD or standard chow food (NC group) were used as control. a Representative photographs of HE-stained liver sections. Insets contain images of whole liver tissue section. The regions of interest (ROI) are boxed in white, and their magnified images are shown at the right. b Representative photographs of oil Red O stained liver sections. The regions of interest (ROI) are boxed in white, and their magnified images are shown at the right
